Now Monsanto—like IBM and Google—has drawn scrutiny from U.S. antitrust investigators, who under the Obama administration have looked more skeptically at the actions of dominant firms.
You can add Intel* to this list and what do you have? Four of the most innovative and successful companies of all time.
I think Monsanto will be a standout biotech stock over the next 5-10 years. If I had to own only one stock for this duration—biotech or otherwise—MON might well be my pick.
Readers who are interested in MON and related topics may find these iHub boards of interest: